Document is current
Any future updates will be listed below
-
Authors
Huemer, Marie-Theres https://orcid.org/0000-0002-4329-8607
Spagnuolo, Maria C. https://orcid.org/0009-0003-3228-8766
Maalmi, Haifa https://orcid.org/0000-0002-2910-1142
Wagner, Robert https://orcid.org/0000-0002-6120-0191
Bönhof, Gidon J. https://orcid.org/0000-0003-1446-6592
Heier, Margit https://orcid.org/0000-0002-7317-7566
Koenig, Wolfgang https://orcid.org/0000-0002-2064-9603
Rathmann, Wolfgang https://orcid.org/0000-0001-7804-1740
Prystupa, Katsiaryna https://orcid.org/0000-0003-3368-1028
Nano, Jana https://orcid.org/0000-0003-4731-5491
Ziegler, Dan https://orcid.org/0000-0001-8956-3552
Peters, Annette https://orcid.org/0000-0001-6645-0985
Roden, Michael https://orcid.org/0000-0001-8200-6382
Thorand, Barbara https://orcid.org/0000-0002-8416-6440
Herder, Christian https://orcid.org/0000-0002-2050-093X
-
Funding
Funding for this research was provided by:
Universitätsklinikum Düsseldorf. Anstalt öffentlichen Rechts
- License Information
-
More Information
Article History
Received: 9 December 2024
Accepted: 27 January 2025
First Online: 19 February 2025
Declarations
:
: The KORA study was carried out in accordance with the Declaration of Helsinki. All study participants gave written informed consent. The Ethics Committee of the Bavarian Medical Association approved the studies (S4 Study: EC No. 99186, F4 study and FF4 study: EC No. 06068).
: Not applicable.
: MR received lecture fees or served on advisory boards for AstraZeneca, Echosens, Eli Lilly, Madrigal, Merck-MSD, Novo Nordisk and Target RWE and performed investigator-initiated research with support from Boehringer Ingelheim, Novo Nordisk and Nutricia/Danone to the German Diabetes Center (DDZ). All other authors declare that they have no competing interests.
